Xtant Medical Holdings (XTNT) Finished Goods (2019 - 2025)

Xtant Medical Holdings (XTNT) has reported Finished Goods for 7 consecutive years, with $19.8 million the latest figure, recorded in Q4 2025.

• On a quarterly basis, Finished Goods fell 32.28% year-over-year to $19.8 million in Q4 2025; TTM through Dec 2025 was $19.8 million, a 32.28% decrease from a year earlier, with the FY2025 full-year figure at $19.8 million, down 32.28% from the prior year.
• Finished Goods was $19.8 million for Q4 2025 at Xtant Medical Holdings, down from $30.6 million in the prior quarter.
• Over five years, Finished Goods peaked at $31.9 million in Q3 2024 and troughed at $10.6 million in Q2 2022.
• A 5-year average of $20.6 million and a median of $18.1 million in 2021 frame the typical range for Finished Goods.
• Across the five-year window, Finished Goods jumped 158.62% in 2024 and sank 32.28% in 2025, its largest moves.
• Over 5 years, Finished Goods stood at $11.8 million in 2021, then declined by 7.67% to $10.9 million in 2022, then soared by 158.35% to $28.1 million in 2023, then advanced by 4.08% to $29.2 million in 2024, then slumped by 32.28% to $19.8 million in 2025.
• The last three Finished Goods figures came in at $19.8 million (Q4 2025), $30.6 million (Q3 2025), and $31.2 million (Q2 2025), per Business Quant data.